This is a Validated Antibody Database (VAD) review about Rhesus mon.. IL7R, based on 32 published articles (read how Labome selects the articles), using IL7R antibody in all methods. It is aimed to help Labome visitors find the most suited IL7R antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
IL7R synonym: interleukin-7 receptor subunit alpha

BioLegend
mouse monoclonal (A019D5)
  • flow cytometry; human; 1:33; loading ...; fig 6g
BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples at 1:33 (fig 6g). Gastroenterology (2019) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; tbl s1
BioLegend IL7R antibody (Biolegend, A019D5) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 5b
BioLegend IL7R antibody (Biolegend, 351309) was used in flow cytometry on human samples (fig 5b). Nat Immunol (2018) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 1a
BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples (fig 1a). Bone Marrow Transplant (2018) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; mouse; loading ...; fig 4f
BioLegend IL7R antibody (Biolegend, A019D5) was used in flow cytometry on mouse samples (fig 4f). J Exp Med (2018) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 3a
BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples (fig 3a). J Exp Med (2018) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 5a
BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples (fig 5a). J Exp Med (2018) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 7a
BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples (fig 7a). Nat Immunol (2018) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human
In order to investigate the role of dopamine in B cell maturation in germinal centres, BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples . Nature (2017) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 2b
BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples (fig 2b). Sci Rep (2017) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig s3c
In order to report that autosomal recessive, partial Go-Ichi-Ni-San 1 deficiency impairs DNA replication and underlies intra-uterine and postnatal growth retardation, chronic neutropenia, and natural killer cell deficiency, BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples (fig s3c). J Clin Invest (2017) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; tbl s9
In order to optimize and assess potential malaria vaccine regimens, BioLegend IL7R antibody (BioLegend, 351310) was used in flow cytometry on human samples (tbl s9). Nature (2017) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; mouse; 1:200; fig 8f
In order to find that armadillo repeat containing 5 is crucial in fetal development, T-cell function and adrenal gland growth homeostasis, BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on mouse samples at 1:200 (fig 8f). Nat Commun (2017) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 2e
In order to observe that the use of chimeric antigen receptor technology is a clinically applicable refinement of regulatory T cell therapy for organ transplantation, BioLegend IL7R antibody (Biolegend, A019D5) was used in flow cytometry on human samples (fig 2e). Am J Transplant (2017) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 7b
In order to determine which cells express CD83, BioLegend IL7R antibody (BioLegend, AO19D5) was used in flow cytometry on human samples (fig 7b). J Immunol (2016) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; fig 7
BioLegend IL7R antibody (Biolegend, 351317) was used in flow cytometry on human samples (fig 7). PLoS ONE (2016) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...
In order to assess how ABCG1 loss in T cells affects atherosclerosis, BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples . J Clin Invest (2016) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig s2
In order to study the pharmacologic inhibition of PI3K and MEK pathways in mixed cultures of human mononuclear cells., BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples (fig s2). Am J Transplant (2016) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 1a
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend IL7R antibody (biolegend, A019D5) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 8a
BioLegend IL7R antibody (Biolegend, 8019D5) was used in flow cytometry on human samples (fig 8a). PLoS Pathog (2016) ncbi
mouse monoclonal (A019D5)
BioLegend IL7R antibody (BioLegend, 351306) was used . Nat Commun (2015) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 4c
In order to discuss the importance of IL-5 positive Th2 cells to allergies, BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples (fig 4c). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; fig s4
In order to assess arming of MAIT cell cytolytic antimicrobial activity and induction by IL-7 and faulty in HIV-1 infection, BioLegend IL7R antibody (Biolegend, A019D5) was used in flow cytometry on human samples (fig s4). PLoS Pathog (2015) ncbi
mouse monoclonal (A019D5)
  • immunohistochemistry; human; 1:20; fig 4
BioLegend IL7R antibody (Biolegend, 351312) was used in immunohistochemistry on human samples at 1:20 (fig 4). Reproduction (2015) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; fig 6
In order to report the phase I trial results of CDX-301, BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples (fig 6). Bone Marrow Transplant (2015) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human
BioLegend IL7R antibody (Biolegend, 351310) was used in flow cytometry on human samples . Scand J Immunol (2015) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; fig 1
BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human
BioLegend IL7R antibody (Biolegend, 351324) was used in flow cytometry on human samples . Hum Immunol (2015) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human
BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples . Nat Commun (2014) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 2f
In order to discuss the therapeutic use of ex vivo-generated Akt-inhibited minor histocompatibility antigen-specific CD8+ T cells, BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples (fig 2f). Blood (2014) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BioLegend IL7R antibody (Biolegend, A019D5) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human
BioLegend IL7R antibody (Biolegend, clone A019D5) was used in flow cytometry on human samples . Mol Ther (2014) ncbi
Articles Reviewed
  1. Karimzadeh H, Kiraithe M, Oberhardt V, Salimi Alizei E, Bockmann J, Schulze zur Wiesch J, et al. Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8+ T Cells and Evolve at the Population Level. Gastroenterology. 2019;156:1820-1833 pubmed publisher
  2. Dias J, Boulouis C, Gorin J, van den Biggelaar R, Lal K, Gibbs A, et al. The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool. Proc Natl Acad Sci U S A. 2018;115:E11513-E11522 pubmed publisher
  3. Kong X, Martinez Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick E, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19:973-985 pubmed publisher
  4. Inoue Y, Endo S, Matsuno N, Kikukawa Y, Shichijo T, Koga K, et al. Safety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2018;: pubmed publisher
  5. Moalli F, Ficht X, Germann P, Vladymyrov M, Stolp B, de Vries I, et al. The Rho regulator Myosin IXb enables nonlymphoid tissue seeding of protective CD8+ T cells. J Exp Med. 2018;215:1869-1890 pubmed publisher
  6. Li N, van Unen V, Höllt T, Thompson A, van Bergen J, Pezzotti N, et al. Mass cytometry reveals innate lymphoid cell differentiation pathways in the human fetal intestine. J Exp Med. 2018;215:1383-1396 pubmed publisher
  7. Seki A, Rutz S. Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells. J Exp Med. 2018;215:985-997 pubmed publisher
  8. Zemmour D, Zilionis R, Kiner E, Klein A, Mathis D, Benoist C. Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR. Nat Immunol. 2018;19:291-301 pubmed publisher
  9. Papa I, Saliba D, Ponzoni M, Bustamante S, Canete P, Gonzalez Figueroa P, et al. TFH-derived dopamine accelerates productive synapses in germinal centres. Nature. 2017;547:318-323 pubmed publisher
  10. Allan D, Cerdeira A, Ranjan A, Kirkham C, Aguilar O, Tanaka M, et al. Transcriptome analysis reveals similarities between human blood CD3- CD56bright cells and mouse CD127+ innate lymphoid cells. Sci Rep. 2017;7:3501 pubmed publisher
  11. Cottineau J, Kottemann M, Lach F, Kang Y, Vély F, Deenick E, et al. Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest. 2017;127:1991-2006 pubmed publisher
  12. Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka A, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445-449 pubmed publisher
  13. Hu Y, Lao L, Mao J, Jin W, Luo H, Charpentier T, et al. Armc5 deletion causes developmental defects and compromises T-cell immune responses. Nat Commun. 2017;8:13834 pubmed publisher
  14. Boardman D, Philippeos C, Fruhwirth G, Ibrahim M, Hannen R, Cooper D, et al. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection. Am J Transplant. 2017;17:931-943 pubmed publisher
  15. Ju X, Silveira P, Hsu W, Elgundi Z, Alingcastre R, Verma N, et al. The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population. J Immunol. 2016;197:4613-4625 pubmed
  16. Gusscott S, Jenkins C, Lam S, Giambra V, Pollak M, Weng A. IGF1R Derived PI3K/AKT Signaling Maintains Growth in a Subset of Human T-Cell Acute Lymphoblastic Leukemias. PLoS ONE. 2016;11:e0161158 pubmed publisher
  17. Cheng H, Gaddis D, Wu R, McSkimming C, Haynes L, Taylor A, et al. Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis. J Clin Invest. 2016;126:3236-46 pubmed publisher
  18. Zwang N, Zhang R, Germana S, Fan M, Hastings W, Cao A, et al. Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways. Am J Transplant. 2016;16:2624-38 pubmed publisher
  19. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed publisher
  20. James E, Gates T, LaFond R, Yamamoto S, Ni C, Mai D, et al. Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome. PLoS Pathog. 2016;12:e1005375 pubmed publisher
  21. Miles B, Miller S, Folkvord J, Kimball A, Chamanian M, Meditz A, et al. Follicular regulatory T cells impair follicular T helper cells in HIV and SIV infection. Nat Commun. 2015;6:8608 pubmed publisher
  22. Mitson Salazar A, Yin Y, Wansley D, Young M, Bolan H, Arceo S, et al. Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function. J Allergy Clin Immunol. 2016;137:907-18.e9 pubmed publisher
  23. Leeansyah E, Svärd J, Dias J, Buggert M, Nyström J, Quigley M, et al. Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection. PLoS Pathog. 2015;11:e1005072 pubmed publisher
  24. James J, Hurley D, Gamage T, Zhang T, Vather R, Pantham P, et al. Isolation and characterisation of a novel trophoblast side-population from first trimester placentae. Reproduction. 2015;150:449-62 pubmed publisher
  25. Anandasabapathy N, Breton G, Hurley A, Caskey M, Trumpfheller C, Sarma P, et al. Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers. Bone Marrow Transplant. 2015;50:924-30 pubmed publisher
  26. Dyring Andersen B, Bonefeld C, Bzorek M, Løvendorf M, Lauritsen J, Skov L, et al. The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8+ IL-17+ T Cells in Psoriasis Lesions. Scand J Immunol. 2015;82:84-91 pubmed publisher
  27. Rochman Y, Yukawa M, Kartashov A, Barski A. Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig. PLoS ONE. 2015;10:e0122198 pubmed publisher
  28. Misra R, Shah S, Fowell D, Wang H, Scheible K, Misra S, et al. Preterm cord blood CD4⁺ T cells exhibit increased IL-6 production in chorioamnionitis and decreased CD4⁺ T cells in bronchopulmonary dysplasia. Hum Immunol. 2015;76:329-338 pubmed publisher
  29. Willmann K, Klaver S, DoÄŸu F, Santos Valente E, Garncarz W, Bilic I, et al. Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity. Nat Commun. 2014;5:5360 pubmed publisher
  30. van der Waart A, van de Weem N, Maas F, Kramer C, Kester M, Falkenburg J, et al. Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy. Blood. 2014;124:3490-500 pubmed publisher
  31. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher
  32. Ito S, Bollard C, Carlsten M, Melenhorst J, Biancotto A, Wang E, et al. Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers. Mol Ther. 2014;22:1388-1395 pubmed publisher